Mallinckrodt Pharmaceuticals plc Announces Business Expansion; Announces Board Appointments
As the business continues efforts to build out its broader commercial organization, Hugh O'Neill, Senior vice president and President, Specialty Pharmaceuticals, will assume responsibility for all specialty pharmaceutical commercial operations, including the hospital organization which he currently oversees and, in the interim, the sales, support and service activities for the recently acquired ARD business. O'Neill will also continue to have responsibility for the company's broad market access activities. Phillips and O'Neil will continue to serve as members of Mallinckrodt's Executive Committee, and report directly to Trudeau. Both executives' appointments are effective January 7, 2015.